Adolescent Depression Clinical Trial
Official title:
Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study.
Adolescence is a critical period for the development of depressive disorders. As adolescence
also is a critical period for brain maturation, it may be hypothesized that maturation
changes in emotional circuits could underlie vulnerability for depression.
The aims of the study are (1) to identify the changes in brain morphometry, white matter
microstructure, and functioning, in networks associated with depression features in
adolescents, and (2) to assess the effects of treated pathology on brain structure by
comparing the neuroimaging measures obtained in adolescents at inclusion with those at
follow-up.
Adolescence is a key development period for neurobiological processes underlying emotional
and cognitive functions in adulthood. The pathophysiology of mood disorders has recently been
associated with maturation changes in brain networks, but little is known on the early brain
structure changes associated with depression appearing during this major brain maturation
period.
The hypothesis of altered structural integrity of limbic prefrontal pathways emerges from the
literature on depression, but it is unknown whether it is also detectable in adolescents with
depression. Thus, we aim to investigate WM and GM structure and anatomy, and functional
correlates of behavioral responses in depressed adolescents.
40 adolescents with a Major Depressive Episode will be investigated using structural T1
magnetic-resonance imaging and diffusion tensor imaging (DTI), at inclusion and after
one-year follow-up. Additionally, they will be investigated with fMRI.
Covariation patterns between neuroimaging and behavioural/clinical variables will be
assessed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00399776 -
Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
|
N/A | |
Completed |
NCT04603053 -
Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT
|
N/A | |
Completed |
NCT01802437 -
An Adaptive Treatment Strategy for Adolescent Depression
|
Phase 1/Phase 2 | |
Completed |
NCT06325605 -
Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression
|
N/A | |
Completed |
NCT02017535 -
An Adaptive Treatment Strategy for Adolescent Depression-Continuation
|
Phase 1/Phase 2 | |
Completed |
NCT03154008 -
Predictors of Response to Treatment for Depression
|
N/A | |
Recruiting |
NCT04613453 -
Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine
|
Phase 2 | |
Terminated |
NCT00284791 -
Lamotrigine in Treatment Resistant Depression in Adolescents
|
N/A | |
Completed |
NCT00312897 -
Omega-3 Fatty Acids in Adolescent Depression
|
Phase 2 | |
Recruiting |
NCT06072677 -
Adolescent Mood During Puberty and Testosterone
|
N/A | |
Recruiting |
NCT01170520 -
Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents
|
Phase 1/Phase 2 |